Validation of the WHO 2016 proposals for Myelodysplastic syndromes patients with the presence of ring sideroblasts but without excess blasts

Br J Haematol. 2017 Sep;178(5):813-816. doi: 10.1111/bjh.14168. Epub 2016 Jun 13.

Yi Li¹, Rui Cui², Tiejun Qin³, Zefeng Xu^{1

3}, Yue Zhang^{1

3}, Wenyu Cai⁴, Wen Cui⁴, Jinqin Liu¹, Bing Li^{1

3}, Zhijian Xiao^{1

3}

¹ State Key Laboratory of Experimental Haematology, Institute of Haematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
² Department of Haematology, Tianjin First Central Hospital, Tianjin, China.
³ MDS and MPN Centre, Institute of Haematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
⁴ Department of Pathology, Institute of Haematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.

No abstract available

Keywords: SF3B1; WHO 2016 classification; myelodysplastic syndromes; ring sideroblasts.

Publication types